Most digital pathology ROI discussions stall because success was never quantified and the manual processes were not recorded as a baseline.
Leadership agrees modernization is necessary. But when it’s time to justify investment, the conversation becomes abstract: improved collaboration, better flexibility, stronger recruitment positioning. They are all important, but none of them are measurable.
ROI moves forward when you anchor it to existing friction. Slide transport time and cost. Diagnostic delays. Manual case reassignment and repeated distribution. Recut frequency and timing for access to new slides. If those inefficiencies aren’t baseline-measured, improvement – and cost savings – can’t be proven.
Digital transformation doesn’t need hype. It needs pre-defined performance thresholds. If you can’t say what must improve within 6 months, 12 months, the evaluation will stay theoretical — and so will the decision.
We explore how leading labs structure measurable adoption, and why evaluations slow down without them, in our full analysis, Digital Pathology Adoption Challenges: A Practical Guide for Pathologists and Lab Directors.
